Epstein Becker Green represented a private equity firm and its portfolio company in the strategic acquisition of a consumer product, cosmetic and over-the-counter (OTC) drug contract manufacturing business. Our team provided life sciences regulatory due diligence support, including an assessment of manufacturing quality compliance through EBG Advisors quality system expert resources.
Results may vary depending on your particular facts and legal circumstances.
People
- Board of Directors / Member of the Firm
- Member of the Firm
- Member of the Firm